Last reviewed · How we verify
NCT05215197
Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation
NA trial testing intracochlear platelet rich fibrin administration in Hearing Loss, Sensorineural in 10 participants. Currently enrolling.
1 December 2025
Quick facts
| Lead sponsor | Pamukkale University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 10 |
| Start date | 31 January 2022 |
| Primary completion | 1 December 2025 |
| Estimated completion | 20 December 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- intracochlear platelet rich fibrin administration — full drug profile →
Conditions studied
- Hearing Loss, Sensorineural — all drugs for Hearing Loss, Sensorineural →
Sponsor
Pamukkale University
Who can join
Eligibility, any sex, with Hearing Loss, Sensorineural. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Fibrosis due to surgical trauma is a common problem with cochlear implants. Fibrosis limits the effectiveness of implant and increases the power consumption. Our aim in this study is to benefit from the anti-inflammatory effects of autologous platelet-rich fibrin to reducing the fibrotic cascade.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05215197
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hearing Loss, Sensorineural
Currently open trials in the same condition.
- NCT06499805 — Barriers and Facilitators to OTC Hearing Aids Success · NA · recruiting
- NCT06560918 — Self-efficacy-based Auditory Rehabilitation With Over-the-Counter Hearing Aids · NA · recruiting
- NCT06882889 — Comparing the Efficacy of Domestic Versus Imported Hearing Aids in ARHL · NA · recruiting
- NCT06664697 — Post-Market Clinical Investigation of the IotaSOFT Insertion System · recruiting
- NCT06268340 — Hearing and Structure Preservation Via ECochG · NA · recruiting
Other Pamukkale University trials
Trials by the same sponsor.
- NCT06667856 — Foot Core Exercise Training With Telerehabilitation · NA · suspended
- NCT07532499 — EMG-Triggered Electrical Stimulation After Median/Ulnar Nerve Repairs · NA · not yet recruiting
- NCT07473232 — Comparison of Platelet-rich Plasma and Activated Cytokine-rich Serum Injection Treatments in Patients With Knee Osteoart · NA · not yet recruiting
- NCT07520084 — Predictors of Climate Change Health Literacy in Older Individuals · recruiting
- NCT07388316 — Functional Improvement and Fine Dexterity in Thumb Tendon Injuries · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05215197 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pamukkale University
- Last refreshed: 27 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05215197.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing